Welcome to datamethods [general] (2)
DSMB Blinding: Yes or No? [general] (9)
Proofs of Nulls: P > 0.05 [study interpretation] (15)
Who to read in snp/gwas/personalised medicine? [data analysis] (2)
Assigning time zero in an observational comparative effectiveness study [design] (2)
A prescription for more precision in defining areas of expertise [general] (5)
Responder Analysis: Loser x 4 [measurement] (3)
How to teach probability ( 2 3 ) [statistical] (44)
Interim Analysis & "Alpha Spending" in RCT's using Bayesian Analyses [bayes] (3)
Is there a reasonable way to report a summary measure in the presence of effect modification? [study interpretation] (2)
Should the Neyman-Pearson lemma remain dominant in the health sciences? [research methods] (5)
Calibration Curves for Clinical Prediction Models [model validation] (6)
Glossary of Statistical Terms [statistical] (15)
Event-free survival > Overall survival? [data analysis] (7)
Sensitivity, specificity, and ROC curves are not needed for good medical decision making ( 2 ) [diagnosis] (34)
Hazard ratio plots with non-linear & time-varying effects in R [general] (19)
Mixed vs Random Effects ICC [measurement] (7)
Event definition for survival analysis [data analysis] (3)
How to derive survival time on anonomised dates [data problems] (1)
Looking for guidance on model design for cohort study with recurrent events [modeling strategy] (4)
Rebranding of "Statistics" as "Machine Learning" to Sound More Impactful & Negative Fallout ( 2 ) [machine learning] (22)
Time-dependent random effects in survival analysis [general] (3)
Language for communicating frequentist results about treatment effects ( 2 3 4 5 ) [study interpretation] (94)
Predicted probabilities for the entire population with nested case-control studies [general] (7)
Inequality of Variances in an RCT [general] (13)
"Observed Power" and other "Power" Issues ( 2 ) [formal] (32)
Critical Appraisal Checklist for Statistical Methods [statistical] (12)
When is testing superior to estimation? [study interpretation] (10)
Comparing 2 biomarkers using restricted cubic splines - how-to, interpretation, model building ( 2 3 4 ) [descriptive] (64)
Power and Sample Size Calculations in a "small" Cohort Study [research methods] (2)